Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

InfraReDx Inc.

BioPhotonics
Jan 2007
InfraReDx Inc. of Burlington, Mass., has received 501(k) clearance from the FDA to market its near-infrared spectroscopic system for coronary artery examination. The corporation hopes that the catheter-based, fiber optic device, which has a laser light source, will enable cardiologists to characterize plaque composition and identify potentially rupture-prone lipid-based plaques. Recently, the company closed a $22.3 million round of funding to complete studies and finalize product development in preparation for a 2007 launch of the device.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!